All In Biotech

Drug Trial Radar · NCT06872866

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects

A Phase 1 Food-Effect Study of 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects

Last checked: Nov 20, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Apr 15, 2025

Primary completion

Feb 28, 2026

Study completion Feb 28, 2026

Sponsor

Lead sponsor
Aspargo Labs, IncIndustry
Sponsor type
Industry
First posted
Mar 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 20 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this phase 1 study is to evaluate the food effect of 100 mg Hezkue Turbo® (ASP-001.1, sildenafil) under fed versus 100 mg of Hezkue Turbo® (ASP-001.1, sildenafil) under fasted conditions in healthy adult male subjects

Conditions

  • Erectile Dysfunction

Interventions

  • ASP-001.1Drug

    Oral liquid suspension of sildenafil

  • ASP-001.1Device

    Bottle/pump containing ASP-001.1 suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
  2. AUCtTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
  3. TmaxTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
  4. ThalfTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
  5. KelTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Aspargo Labs

    New York, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.